⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 1, 2002Clinical Pharmacology & Therapeutics

Cytochrome P450 phenotypic ratios for predicting herb‐drug interactions in humans

Bill J. Gurley Stephanie F. Gardner Martha A. Hubbard David Williams W. Brooks Gentry Yanyan Cui C.Y.W. ANG

View at Publisher

Ask AI

Bookmark

Share

Abstract

Single-time point phenotypic metabolic ratios may provide a practical means of predicting CYP-mediated herb-drug interactions in humans.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gurley et al. (2002) studied this question.

synapsesocial.com/papers/69d80c76a2a48916bbbeeb82 https://doi.org/10.1067/mcp.2002.126913

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Proteomic Profiling of Xenobiotic and Nutrient Transporters in Human Placenta of Different Gestational AgesClinical Pharmacology & Therapeutics · Tue,
2A Pilot Randomized Study of NAT2 and YEATS4 Pharmacogenetic Return of Results in Adults with Hypertension and African Ancestry: The GUARDD ‐ US PGx StudyClinical Pharmacology & Therapeutics · Sun,
3ASCPT NewsClinical Pharmacology & Therapeutics · Fri,
4New Approach Methodologies ( NAMs ): Guiding Clinical Predictions through Human‐Relevant EvidenceClinical Pharmacology & Therapeutics · Fri,
5Drug–Drug Interactions vs. Therapeutic Combinations in Patients with Congestive Heart Failure and Diabetes: An Ambispective Real‐World StudyClinical Pharmacology & Therapeutics · Fri,

More from Clinical Pharmacology & Therapeutics

Toward a Platform PBPK Model to Characterize the Plasma and Tissue Disposition of Unconjugated Antisense Oligonucleotides and GalNAc ‐Conjugated Small Interfering RNAs in Preclinical Species and HumanThu,
Reprocessing Mass Spectra from Therapeutic Drug Monitoring to Unveil Proton Pump Inhibitor Use and Quantify Phenoconversion of Escitalopram Metabolism in CYP2C19 ‐Genotyped PatientsWed,
Pharmacokinetics of Rifapentine and Desacetyl Rifapentine in Maternal Plasma and Breast Milk & Infant Cord Blood and Plasma: A Model‐Based Analysis of Mother–Infant Pairs for Tuberculosis PreventionThu,
Advancing Pregnancy and Pediatric Science through the NIH Transporter Elucidation NetworkThu,
CYP2D6 ‐Guided Opioid Therapy for Chronic Pain: A Multi‐Center Pragmatic Randomized Controlled TrialThu,